University of Crete (UOC)
Αξιολόγηση της προγνωστικής σημασίας των κυκλοφορούντων καρκινικών κυττάρων κατά τη διάρκεια της παρακολούθησης ασθενών με πρώιμο καρκίνο μαστού
Abstract
dc:descriptionBackground — the detection of CK-19 mRNA-positive circulating tumor cells (CTC) beforeand/or after adjuvant chemotherapy in patients with operable breast cancer is associatedwith poor clinical outcome. Reliable prognostic markers for late disease relapse are notavailable. In this study we investigated the value of CTC detection during the first 5 years offollow-up in predicting late disease relapse.Patients and Methods — blood was analyzed from 312 women with operable breastcancer who had not experienced disease relapse during the first two years of follow-up. Areal-time RT-PCR for CK-19 mRNA was used for CTC detection three months after thecompletion of adjuvant chemotherapy and every six months thereafter for a 5-year follow-upperiod.Results — eighty (25.6 percent) patients remained CTC-free throughout the 5-year period.A change in CTC status was observed in 133 (42.6 percent) patients; 64 (20.5 percent)patients with initially CK-19 mRNA-positive CTC during the first 24 months turned CTCnegativeafterwards while 69 (22.1 percent) who were initially CTC-negative became CTCpositive.Ninety-nine (31.7 percent) patients remained persistently CK-19 mRNA-positive.After a median follow-up period of 107 months (range: 38-161 months), the persistentlyCTC-positive patients with either hormonal receptor positive or negative tumors, had ahigher risk of late disease relapse compared to the persistently CTC-negative patients (36.4percent versus 11.2 percent, p<0.001). Multivariate analysis revealed that persistentlyCTC-positive patients also had a shorter disease-free (p=0.001) and overall survival(p=0.001).Conclusion — persistent detection of CK-19 mRNA-positive CTC during the first 5 years offollow-up is associated with an increased risk of late relapse and death for patients withoperable breast cancer, indicating the presence of chemotherapy- and hormonotherapyresistantresidual disease. This prognostic evaluation may be useful when deciding onsubsequent adjuvant systemic therapy.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Saloustros, Emmanouil
- Σαλούστρος, Εμμανουήλ
Subjects
dc:subject × 14Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38924